ArticleJAMA network open2024

Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.

Davide Ciardiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.